How medically supervised GLP-1 programs actually work.

What GLP-1 medications are

Glucagon-like peptide-1 (GLP-1) is a hormone your gut releases after meals. It tells your pancreas to release insulin, slows stomach emptying, and dampens appetite signals in the brain. GLP-1 receptor agonists are engineered peptides that mimic this hormone with a much longer half-life — once-weekly dosing instead of minutes. Semaglutide (originally Ozempic / Wegovy) and tirzepatide (Mounjaro / Zepbound) are the two best-known. Tirzepatide also activates the GIP receptor, which is part of why head-to-head trials favor it for weight outcomes.

The mechanism is real, the trial data is strong, and the side-effect profile is well characterized when the program is well run. The qualifier matters.

What a real supervised program includes

A legitimate GLP-1 program is not "prescription delivered to your door." It is a clinical relationship. Expect:

• Clinical intake. Medical history, medications, family history (especially thyroid cancers and pancreatitis), pregnancy plans, eating-disorder history.
• Baseline labs. Comprehensive metabolic panel, lipid panel, HbA1c, often thyroid function and lipase. Some programs add a baseline body-composition scan.
• Eligibility determination by a licensed clinician. Eligibility is not a checkbox. Contraindications include a personal or family history of medullary thyroid cancer, MEN2 syndrome, active pancreatitis, severe GI motility disorders, and pregnancy.
• Nutrition and protein plan. Without explicit protein anchoring (~1.6 g/kg/day) and resistance training, GLP-1 weight loss carries an outsized share of lean tissue. A good program addresses this from day one.
• Titration and check-ins. Dose escalates over weeks. Side effects (nausea, constipation, fatigue) are monitored. Dose can be slowed or paused.
• Off-ramp planning. Discontinuation strategy and weight-maintenance plan from the start — not improvised at month six.

None of this is exotic. All of it should be in the program description before you pay anything.

Who is a candidate — and who isn't

Standard guidelines support pharmacologic weight management for adults with a BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, sleep apnea, dyslipidemia). Eligibility is ultimately a clinician's call — and an honest clinic will sometimes say no.

Common reasons a good clinic will decline a candidate: planning pregnancy in the near term, history of pancreatitis, certain thyroid cancers, untreated eating disorder, weight goal that's cosmetic rather than clinical, or no willingness to address nutrition and training alongside the medication.

What it costs in 2026

• UAE (Dubai, Abu Dhabi): typical all-in programs run AED 1,500–3,500 per month including medication, clinician visits and labs. Pricing varies by tier and brand availability.
• Canada: coverage varies by province. Out-of-pocket, programs typically run CAD 350–700 per month. Some private insurance covers a portion.
• USA: compounded vs. branded creates a wide range — branded programs often $900–1,600 per month all-in, compounded options lower (and regulatory landscape shifting).

Numbers without supervision, lab work, or a real clinician relationship are not cheaper. They're a different product.

Eight questions to ask before you sign up

1. Is the prescribing clinician licensed in my jurisdiction, and can I see their license?
2. Does the program include baseline and follow-up labs?
3. What's the protein and training plan, and who designs it?
4. How is dose escalation handled, and who do I contact about side effects?
5. What's the discontinuation and maintenance plan?
6. Where is the medication sourced from, and is it pharmacy-grade?
7. What's the total monthly cost including labs and check-ins?
8. Under what circumstances would you decline a candidate?

Any clinic that struggles with these is not the clinic you want.

The honest summary

GLP-1 medications are powerful, well-studied, and life-changing for the right candidate with the right supervision. They are also being sold by entities who shouldn't be selling them, to people who haven't been evaluated, without the structural support that makes the weight loss durable. The line between those two worlds is licensed clinical oversight — and that's the line Jevity exists to keep clear.

This article is general education, not medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications requiring evaluation, prescription, and ongoing monitoring by a licensed clinician. Eligibility is never guaranteed. Jevity does not sell, dispense, or ship prescription medication; partner clinics are independent licensed providers responsible for all care decisions. Always consult your physician.